Cargando…

Itch in psoriasis: epidemiology, clinical aspects and treatment options

BACKGROUND: Pruritus is an important symptom in psoriasis vulgaris, may be severe and seriously affect the quality of life of patients, but published data on its frequency and characteristics are limited. OBJECTIVE: The study objective was to characterize the prevalence of itch in psoriatic patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Prignano, F, Ricceri, F, Pescitelli, L, Lotti, T
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047933/
https://www.ncbi.nlm.nih.gov/pubmed/21436964
_version_ 1782199102457511936
author Prignano, F
Ricceri, F
Pescitelli, L
Lotti, T
author_facet Prignano, F
Ricceri, F
Pescitelli, L
Lotti, T
author_sort Prignano, F
collection PubMed
description BACKGROUND: Pruritus is an important symptom in psoriasis vulgaris, may be severe and seriously affect the quality of life of patients, but published data on its frequency and characteristics are limited. OBJECTIVE: The study objective was to characterize the prevalence of itch in psoriatic patients and the effect of treatment modalities by using a comprehensive itch questionnaire of own design. METHODS: A structured itch questionnaire was given to 90 patients with moderate to severe chronic-plaque psoriasis selected consecutively from the patients visiting the Department of Dermatology of the University of Florence. The questionnaire concerned the areas involved psoriasis and pruritus, the pruritus characteristics, the worsening and relieving factors and treatment modalities. Itch intensity was reflected by a 10 point visual analog scale (VAS) and the degree of symptoms discriminated between mild (1–3), moderate (4–7) and severe (8–10). RESULTS: Almost 85% of psoriatic patients suffered from itching; the frequency of pruritus was daily and mean intensity by VAS scale was moderate. Presence and intensity of pruritus and body mass index (BMI) were correlated. 40% of patients with pruritus were overweight (BMI > 25 < 30) and 10% obese (BMI > 30). Almost all patients appeared unsatisfied with the available treatment modalities for pruritus in psoriasis. Emollients, topical steroids and calcipotriol cream could relieve pruritus but their effect was temporary. Among the antipsoriatic therapies, phototherapy with narrow band ultraviolet B (nb-UVB) was the most effective treatment in reducing pruritus. Biological therapies, mainly etanercept and efalizumab, proved useful in its control. CONCLUSIONS: The questionnaire was a useful tool to characterize itch, and the results might help us to better understand pruritus in psoriasis. The results confirmed the need for a global study of psoriasis with regard to both the cutaneous manifestations and the itch symptom.
format Text
id pubmed-3047933
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-30479332011-03-23 Itch in psoriasis: epidemiology, clinical aspects and treatment options Prignano, F Ricceri, F Pescitelli, L Lotti, T Clin Cosmet Investig Dermatol Original Research BACKGROUND: Pruritus is an important symptom in psoriasis vulgaris, may be severe and seriously affect the quality of life of patients, but published data on its frequency and characteristics are limited. OBJECTIVE: The study objective was to characterize the prevalence of itch in psoriatic patients and the effect of treatment modalities by using a comprehensive itch questionnaire of own design. METHODS: A structured itch questionnaire was given to 90 patients with moderate to severe chronic-plaque psoriasis selected consecutively from the patients visiting the Department of Dermatology of the University of Florence. The questionnaire concerned the areas involved psoriasis and pruritus, the pruritus characteristics, the worsening and relieving factors and treatment modalities. Itch intensity was reflected by a 10 point visual analog scale (VAS) and the degree of symptoms discriminated between mild (1–3), moderate (4–7) and severe (8–10). RESULTS: Almost 85% of psoriatic patients suffered from itching; the frequency of pruritus was daily and mean intensity by VAS scale was moderate. Presence and intensity of pruritus and body mass index (BMI) were correlated. 40% of patients with pruritus were overweight (BMI > 25 < 30) and 10% obese (BMI > 30). Almost all patients appeared unsatisfied with the available treatment modalities for pruritus in psoriasis. Emollients, topical steroids and calcipotriol cream could relieve pruritus but their effect was temporary. Among the antipsoriatic therapies, phototherapy with narrow band ultraviolet B (nb-UVB) was the most effective treatment in reducing pruritus. Biological therapies, mainly etanercept and efalizumab, proved useful in its control. CONCLUSIONS: The questionnaire was a useful tool to characterize itch, and the results might help us to better understand pruritus in psoriasis. The results confirmed the need for a global study of psoriasis with regard to both the cutaneous manifestations and the itch symptom. Dove Medical Press 2009-02-19 /pmc/articles/PMC3047933/ /pubmed/21436964 Text en © 2009 Prignano et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited.
spellingShingle Original Research
Prignano, F
Ricceri, F
Pescitelli, L
Lotti, T
Itch in psoriasis: epidemiology, clinical aspects and treatment options
title Itch in psoriasis: epidemiology, clinical aspects and treatment options
title_full Itch in psoriasis: epidemiology, clinical aspects and treatment options
title_fullStr Itch in psoriasis: epidemiology, clinical aspects and treatment options
title_full_unstemmed Itch in psoriasis: epidemiology, clinical aspects and treatment options
title_short Itch in psoriasis: epidemiology, clinical aspects and treatment options
title_sort itch in psoriasis: epidemiology, clinical aspects and treatment options
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3047933/
https://www.ncbi.nlm.nih.gov/pubmed/21436964
work_keys_str_mv AT prignanof itchinpsoriasisepidemiologyclinicalaspectsandtreatmentoptions
AT riccerif itchinpsoriasisepidemiologyclinicalaspectsandtreatmentoptions
AT pescitellil itchinpsoriasisepidemiologyclinicalaspectsandtreatmentoptions
AT lottit itchinpsoriasisepidemiologyclinicalaspectsandtreatmentoptions